Healthcare & Life Sciences

USPTO Grants Patent for Single Molecule Peptide Sequencing

The USPTO has granted a patent (US12578345B2) to The University of Texas System for methods of single molecule peptide sequencing. The patent covers techniques for identifying polypeptide sequences within a mixture by immobilizing, labeling, and analyzing the polypeptide.

USPTO Patent Grant US12581852B2 for Luminescent Material

The United States Patent and Trademark Office (USPTO) has granted patent US12581852B2 to KYULUX, INC. for a compound useful as a light-emitting material. The patent covers specific chemical formulas and their application in organic optical devices.

Samsung Display Patent for Organic Compound Sensor Display

The USPTO has granted Samsung Display Co., Ltd. a patent for an organic compound sensor display. The patent, US12581853B2, covers an organic compound represented by Chemical Formula 1 and its application in sensor-embedded display panels and electronic devices. The filing date was September 28, 2022.

USPTO Patent Grant: Bioprobes for Amine Oxidase Enzymes

The USPTO has granted a patent (US12578335B2) to Syntara Limited for novel bioprobes designed to detect and quantify amine oxidase enzymes. These bioprobes are intended for use in assessing enzyme concentrations and inhibition levels in various samples.

USPTO Patent Grant for Light-Emitting Element

The USPTO has granted patent US12581794B2 for a light-emitting element developed by Semiconductor Energy Laboratory Co., Ltd. The patent covers a specific design for a light-emitting element utilizing a phosphorescent compound and an exciplex formed by organic compounds.

USPTO Patent Grant: Sag Compensation Deformable Lens

The USPTO has granted Apple Inc. a patent (US12578511B1) for a sag compensation structure for deformable lenses. This structure aims to mitigate gravity-induced sag in deformable lens membranes, potentially improving optical performance in lens assemblies.

USPTO Patent Grant US12578593B2: Spiral Dioptre

The USPTO has granted patent US12578593B2 for a spiral dioptre with meridians of different optical power, assigned to SPIRAL. This patent relates to optical devices designed to provide a focused tubular region.

USPTO Patent US12578700B2: 3D Printing Microstructures File Format

The USPTO has granted patent US12578700B2 to OPT Industries, Inc. for systems, methods, and a new file format for 3D printing microstructures. The patent describes a wireframe model expressed as a collection of wires for defining 3D objects, enabling the printing of novel items like eyelashes and swabs.

USPTO Patent US12579812B2: Tip type verification using image processing

The USPTO has granted patent US12579812B2 to Johnson & Johnson Surgical Vision, Inc. for a method of verifying the tip type of an ophthalmic instrument using image processing. The patent describes a system that acquires an image of the tip, identifies its visual properties, and compares them to stored definitions to ensure the correct tip type is selected for a medical procedure.

USPTO Grants Bone Conduction Device Patent to Cochlear Limited

The USPTO has granted a patent (US12581254B2) to Cochlear Limited for a bone conduction device. The patent covers an external component with a quick-connect feature for a vibrator and platform, designed to transfer vibrations to the recipient's skin. The patent was granted on March 17, 2026.

USPTO Grants Design Patent for Mouthguard

The USPTO has granted a design patent (USD1119093S1) for a mouthguard to DCSTAR INC. The patent covers the ornamental design of the mouthguard, with a filing date of January 27, 2025, and an issue date of March 17, 2026. This grant signifies a new intellectual property right for the assignee.

USPTO Patent Grant: Depilatory Device

The United States Patent and Trademark Office (USPTO) has granted a design patent for a depilatory device. The patent, identified as USD1119080S1, was granted on March 17, 2026, to inventor Kai Dou. This grant signifies the protection of the unique design of the device.

USPTO Patent Grant for Mint Labs Inc. Tractography Image Diagnosis Methods

The USPTO has granted a patent to Mint Labs Inc. for systems and methods to improve tractography images used in diagnosing neurodegenerative diseases. The patent, Reissue USRE050823E1, focuses on enhancing diffusion-based magnetic resonance imaging for damaged nervous systems, potentially serving as a biomarker for patient assessment.

USPTO Grants Medical Instrument Patent to Shanghai United Imaging

The USPTO has granted a design patent (USD1118971S1) for a medical instrument to Shanghai United Imaging Microelectronics Technology Co., Ltd. The patent covers a design related to diagnosis and surgery, with a filing date of August 21, 2024.

Sumitomo Pharma Design Patent Grant for Dish

The USPTO has granted a design patent (USD1118970S1) for a dish to Sumitomo Pharma Co., Ltd., with an effective date of March 17, 2026. The patent covers a specific design related to diagnostic or surgical applications, as indicated by its CPC classifications.

Anti-CSF1R Antibodies and Pharmaceutical Compositions Patent

The USPTO has granted patent US12577309B2 for anti-CSF1R antibodies, pharmaceutical compositions, and their uses. The patent was assigned to DRAGONBOAT BIOPHARMACEUTICAL (SHANGHAI) CO., LTD. and lists six inventors. The patent's abstract describes antibodies against human CSF-1R.

USPTO Patent Grant: Diagnostic Antibodies Against MUC17

The USPTO has granted patent US12577322B2 to Amgen Inc. for diagnostic antibodies against mucin 17 (MUC17). These antibodies and associated detection systems are intended for detecting, quantifying, and monitoring MUC17 related to disease diagnosis, progression, and therapeutic response.

USPTO Patent Grant for Bispecific Antibodies

The USPTO has granted a patent (US12577314B2) to ABL BIO INC. for bispecific antibodies designed to treat diseases related to BCMA and/or 4-1BB proteins. The patent covers the antibody's structure and its therapeutic applications.

US Patent 12577313B2 for Bispecific Antibodies

The USPTO has granted US Patent 12577313B2 for bispecific antibodies targeting claudin 18.2 and 4-1BB, assigned to I-Mab Biopharma US Limited. The patent covers novel antibody designs that can trigger tumor-specific immune responses.

CMS Rule Phases Out Fax, Mail for Electronic Transactions

CMS has issued a final rule to phase out fax and mail for healthcare claims attachments, replacing them with standardized electronic transactions and electronic signatures. This rule is projected to save the healthcare industry approximately $781 million annually by reducing administrative burdens and improving efficiency.

CMS Finalizes Health Care Claims Attachments and Electronic Signatures Standards

CMS has finalized a rule adopting new HIPAA-adopted standards for health care claims attachments transactions and electronic signatures. This rule aims to enable secure electronic exchange of clinical documentation and is projected to save the healthcare industry approximately $781 million annually.

Potassium Iodide Distribution in Middletown

The Delaware Division of Public Health (DPH) announced a potassium iodide distribution event scheduled for April 2 in Middletown. This distribution is in preparation for potential emergencies at the nearby Salem Hope Creek Nuclear Generating Station.

Delaware DUI Checkpoint and Sober Rides Program Results

The Delaware Office of Highway Safety reported the results of its St. Patrick's Day weekend DUI checkpoint and Sober Rides Program. The initiative led to 23 DUI arrests and two fatalities over the holiday weekend, with 1,144 individuals utilizing the Sober Rides program.

DSHA Launches Healthy Heart Program for Public Housing Residents

The Delaware State Housing Authority (DSHA) has launched a new Healthy Heart Program aimed at improving the cardiovascular health of residents in public housing. This initiative was announced on March 20, 2026, and focuses on community health and wellness.

DEA Phoenix Operation Mechanic Results Highlighted

The DEA Phoenix Field Division, in partnership with law enforcement agencies, announced the results of Operation Mechanic. This operation focused on combating fentanyl trafficking and related criminal activities, contributing to a broader national effort to reduce drug-related harm.

DEA Seizes 30,000 Fentanyl Pills and 15 Kgs Powder

The DEA announced the seizure of 30,000 fentanyl pills and 15 kilograms of fentanyl powder as part of Operation FentanylFreeAmerica Phase 2. A trafficker linked to the Sinaloa cartel was arrested during the operation, which involved collaboration with local law enforcement agencies.

FDA Variance Application from Epic Pro Event Production

The FDA has posted a variance application from Epic Pro Event Production. The document is available for review on Regulations.gov, though no specific details or full text are provided in the initial listing.

FDA Variance Approval Letter to Kyle Cummings

The FDA has issued a variance approval letter to Kyle Cummings, as posted on March 20, 2026. The document is restricted due to personally identifiable information and was authored by CDRH.

FDA Variance Renewal from Lapis Lasers & Lighting FX

The FDA has posted a variance renewal request from Lapis Lasers & Lighting FX, LLC. The document is available for review and download via the Regs.gov portal. No specific details on the variance itself are provided in the metadata.

FDA Complaint Document

The FDA has posted a complaint document related to its regulatory activities. No content is available for viewing or download, but an attachment labeled 'Complaint' is provided by the CTP author.

FDA Variance Approval Letter to Mykyta Sukhenko

The FDA's Center for Devices and Radiological Health (CDRH) has issued a variance approval letter to Mykyta Sukhenko. The document is restricted due to personally identifiable information, but a redacted version is available.

FDA Variance Application from Mykyta Sukhenko

The FDA has posted a variance application submitted by Mykyta Sukhenko. The application is restricted due to personally identifiable information, but a redacted version is available for review. This notice serves to inform the public of the application's existence.

FDA Variance Approval Letter for Vault Entertainment Inc.

The Food and Drug Administration (FDA) has issued a variance approval letter to Vault Entertainment Inc. This document grants a specific variance related to regulatory requirements. The FDA's Center for Devices and Radiological Health (CDRH) authored the letter.

FDA Acknowledgment Letter to Kyle Cummings

The FDA has posted an acknowledgment letter sent to Kyle Cummings regarding a submission. The letter is from the FDA's Division of Management and Budget (DMB) and was authored by CDRH. A redacted version is available for download.

FDA Variance Approval Letter to Laser Wizardry

The FDA has issued a variance approval letter to Laser Wizardry regarding a medical device. This document is part of the regulatory process for medical device manufacturers seeking specific approvals or variances from standard requirements.

FDA Variance Approval Letter

The FDA's Center for Devices and Radiological Health (CDRH) has issued a variance approval letter. The document is restricted due to Personally Identifiable Information and a redacted version is available for download.

FDA Acknowledges Letter from 3 Foot World

The FDA has acknowledged receipt of a letter from 3 Foot World regarding a matter associated with docket FDA-2026-V-1589. The agency has provided a link to the acknowledgment letter, which was authored by CDRH.

FDA Complaint Document

The FDA has posted a complaint document related to its regulatory activities. The document is available for review on the Regs.gov platform. No specific details about the nature of the complaint or the parties involved are provided in the metadata.

FDA Variance Application from Life to the Full, LLC

The FDA has posted a variance application from Life to the Full, LLC. The application details are available via a link on the Regs.gov portal. No documents are currently available for direct viewing or download.

FDA Variance Application from Matthew Lewis

The FDA has posted a variance application submitted by Matthew Lewis, with redacted information available for download. This application is related to medical device regulations and was submitted through CDRH.

FDA Variance Approval Letter for Alexander Kulik

The FDA has issued a variance approval letter to Alexander Kulik, as posted on March 20, 2026. The letter, issued by the Center for Devices and Radiological Health (CDRH), pertains to a specific variance request.

FDA Acknowledgment Letter to Mykyta Sukhenko

The Food and Drug Administration (FDA) has posted an acknowledgment letter sent to Mykyta Sukhenko regarding a submission. The letter, authored by the Center for Devices and Radiological Health (CDRH), indicates a formal receipt of information or documentation.

FDA Variance Approval Letter to 3 Foot World

The FDA's Center for Devices and Radiological Health (CDRH) has issued a variance approval letter to 3 Foot World. The document indicates a specific approval for a variance related to a medical device. No further details on the nature of the variance or its implications are provided in the metadata.

FDA Variance Approval Letter to Feral Artisans

The FDA has issued a variance approval letter to Feral Artisans regarding a medical device. The document is available for download and further information can be accessed via the provided link.

FDA Complaint Document

The FDA has closed a complaint document for public comment. The document is related to the Center for Tobacco Products (CTP) and is available for review on regulations.gov. No specific compliance deadlines or actions are detailed in this notice.

FDA Variance Application from Vault Entertainment Inc.

The FDA has received a variance application from Vault Entertainment Inc. The document is a filing related to a variance request, with no downloadable content available directly in the provided feed entry. Further details are available via the provided URL.

FDA Variance Application from Alexander Kulik

The FDA has posted a variance application submitted by Alexander Kulik. The application is from the CDRH (Center for Devices and Radiological Health) and has been redacted for personally identifiable information. The document is available for review on Regs.gov.

FDA Acknowledgment Letter to Life to the Full, LLC

The Food and Drug Administration (FDA) has issued an acknowledgment letter to Life to the Full, LLC. This letter confirms receipt of a submission from the company. The FDA's Center for Devices and Radiological Health (CDRH) is listed as an author.

FDA Variance Application from Illuminate Production Services

The FDA has posted a variance application from Illuminate Production Services. The document is available for review on Regs.gov, with the application submitted by CDRH.

FDA Variance Application from Kyle Cummings

The FDA has posted a variance application submitted by Kyle Cummings. The application is from the CDRH (Center for Devices and Radiological Health) and is available for review, with a redacted version provided for download. No specific details of the variance are available in the provided text.